Professur für Rheumatologie und Klinische Immunologie

Unilateral plantar erythema nodosum in sarcoidosis (2017) Hueber A, Schett G, Manger B Journal article Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis (2017) Fischer S, Rath T, Geppert CI, Manger B, Schett G, Neurath M, Atreya R Journal article FEVER OF UNKNOWN ORIGIN (FUO) AND INFLAMMATION OF UNKNOWN ORIGIN (IUO): IS 18F-FDG-PET/CT A USEFUL FIRST LINE DIAGNOSTIC STRATEGY? (2016) Schoenau V, Vogel K, Engelbrecht M, Schmidt D, Kuwert T, Manger B, Schett G Conference contribution A LONGITUDINAL DUAL ENERGY COMPUTED TOMOGRAPHY STUDY ON THE EFFECT OF URATE LOWERING THERAPIES ON THE REDUCTION OF TOPHUS BURDEN IN PATIENTS WITH CHRONIC GOUT (2016) Ellmann H, Bayat S, D'Oliveira I, Englbrecht M, Araujo E, Mendonca S, Lell M, et al. Conference contribution From 3D Printed Bones to Arthritis Patients - Arthro-Haptic Experience Supporting Disease Awareness (2016) Kleyer A, Beyer L, Simon C, Stemmler F, Rech J, Englbrecht M, Manger B, et al. Conference contribution Effects of DMARD Tapering on Treatment Costs and Work Productivity in Rheumatoid Arthritis Patients- an Analysis from the Prospective Randomized Controlled Retro- Study (2016) Hagen M, Figueiredo CP, Cobra JF, Haschka J, Reiser M, Englbrecht M, Hueber A, et al. Conference contribution ANTI-MODIFIED PROTEIN ANTIBODY RESPONSE PATTERN INFLUENCES THE RISK FOR DISEASE RELAPSE IN RHEUMATOID ARTHRITIS PATIENTS TAPERING DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (2016) Figueiredo C, Bang H, Cobra JF, Englbrecht M, Hueber AJ, Haschka J, Manger B, et al. Conference contribution EFFECTS OF DMARD TAPERING ON TREATMENT COSTS IN RHEUMATOID ARTHRITIS PATIENTS-AN ANALYSIS FROM THE PROSPECTIVE RANDOMIZED CONTROLLED RETROSTUDY (2016) Hagen M, Figueiredo C, Cobra JF, Reiser M, Haschka J, Englbrecht M, Hueber A, et al. Conference contribution Rare rheumatic diseases (2016) Manger B, Swoboda B Journal article, Editorial Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment (2016) Rech J, Hueber A, Finzel S, Englbrecht M, Haschka J, Manger B, Kleyer A, et al. Journal article